Topline data from phase III study of Molgradex in autoimmune alveolar pulmonary proteinosis June 13, 2019 No Comments
Aqualung Therapeutics wins award to support development of therapies for ARDS June 7, 2019 No Comments
Phase III studies of Xolair in chronic rhinosinusitis with nasal polyps meet coprimary endpoints June 3, 2019 No Comments
RSS